Cargando…

Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools

BACKGROUND: Individual mortality risk predicted curve at the individual level can provide valuable information for directing individual treatment decision. The present study attempted to explore potential post-transcriptional biological regulatory mechanism related with overall survival of lung aden...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jinsong, Lu, Shubiao, Jiang, Zhijian, Hu, Chongjing, Zhang, Zhiqiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109009/
https://www.ncbi.nlm.nih.gov/pubmed/34012732
http://dx.doi.org/10.7717/peerj.11412
_version_ 1783690176179994624
author Lin, Jinsong
Lu, Shubiao
Jiang, Zhijian
Hu, Chongjing
Zhang, Zhiqiao
author_facet Lin, Jinsong
Lu, Shubiao
Jiang, Zhijian
Hu, Chongjing
Zhang, Zhiqiao
author_sort Lin, Jinsong
collection PubMed
description BACKGROUND: Individual mortality risk predicted curve at the individual level can provide valuable information for directing individual treatment decision. The present study attempted to explore potential post-transcriptional biological regulatory mechanism related with overall survival of lung adenocarcinoma (LUAD) patients through competitive endogenous RNA (ceRNA) network and develop two precision medicine predictive tools for predicting the individual mortality risk curves for overall survival of LUAD patients. METHODS: Multivariable Cox regression analyses were performed to explore the potential prognostic indicators, which were used to construct a prognostic model for overall survival of LUAD patients. Time-dependent receiver operating characteristic (ROC) curves were used to assess the predictive performance of prognostic model. RESULTS: There were 494 LUAD patients in model cohort and 233 LUAD patients in validation cohort. Differentially expressed mRNAs, miRNAs, and lncRNAs were identified between LUAD tissues and normal tissues. A ceRNA regulatory network was constructed on previous differentially expressed mRNAs, miRNAs, and lncRNAs. Fourteen mRNA biomarkers were identified as independent risk factors by multivariate Cox regression and used to develop a prognostic model for overall survival of LUAD patients. The C-indexes of prognostic model in model group were 0.786 (95% CI [0.744–0.828]), 0.736 (95% CI [0.694–0.778]) and 0.766 (95% CI [0.724–0.808]) for one year, two year and three year overall survival respectively. Two precision medicine predicted tools were developed for predicting individual mortality risk curves for LUAD patients. CONCLUSION: The current study explored potential post-transcriptional biological regulatory mechanism and prognostic biomarkers for overall survival of LUAD patients. Two on-line precision medicine predictive tools were helpful to predict the individual mortality risk predicted curves for overall survival of LUAD patients. Smart Cancer Survival Predictive System could be used at https://zhangzhiqiao2.shinyapps.io/Smart_cancer_predictive_system_9_LUAD_E1002/.
format Online
Article
Text
id pubmed-8109009
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-81090092021-05-18 Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools Lin, Jinsong Lu, Shubiao Jiang, Zhijian Hu, Chongjing Zhang, Zhiqiao PeerJ Bioinformatics BACKGROUND: Individual mortality risk predicted curve at the individual level can provide valuable information for directing individual treatment decision. The present study attempted to explore potential post-transcriptional biological regulatory mechanism related with overall survival of lung adenocarcinoma (LUAD) patients through competitive endogenous RNA (ceRNA) network and develop two precision medicine predictive tools for predicting the individual mortality risk curves for overall survival of LUAD patients. METHODS: Multivariable Cox regression analyses were performed to explore the potential prognostic indicators, which were used to construct a prognostic model for overall survival of LUAD patients. Time-dependent receiver operating characteristic (ROC) curves were used to assess the predictive performance of prognostic model. RESULTS: There were 494 LUAD patients in model cohort and 233 LUAD patients in validation cohort. Differentially expressed mRNAs, miRNAs, and lncRNAs were identified between LUAD tissues and normal tissues. A ceRNA regulatory network was constructed on previous differentially expressed mRNAs, miRNAs, and lncRNAs. Fourteen mRNA biomarkers were identified as independent risk factors by multivariate Cox regression and used to develop a prognostic model for overall survival of LUAD patients. The C-indexes of prognostic model in model group were 0.786 (95% CI [0.744–0.828]), 0.736 (95% CI [0.694–0.778]) and 0.766 (95% CI [0.724–0.808]) for one year, two year and three year overall survival respectively. Two precision medicine predicted tools were developed for predicting individual mortality risk curves for LUAD patients. CONCLUSION: The current study explored potential post-transcriptional biological regulatory mechanism and prognostic biomarkers for overall survival of LUAD patients. Two on-line precision medicine predictive tools were helpful to predict the individual mortality risk predicted curves for overall survival of LUAD patients. Smart Cancer Survival Predictive System could be used at https://zhangzhiqiao2.shinyapps.io/Smart_cancer_predictive_system_9_LUAD_E1002/. PeerJ Inc. 2021-05-07 /pmc/articles/PMC8109009/ /pubmed/34012732 http://dx.doi.org/10.7717/peerj.11412 Text en ©2021 Lin et al. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits using, remixing, and building upon the work non-commercially, as long as it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Bioinformatics
Lin, Jinsong
Lu, Shubiao
Jiang, Zhijian
Hu, Chongjing
Zhang, Zhiqiao
Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools
title Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools
title_full Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools
title_fullStr Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools
title_full_unstemmed Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools
title_short Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools
title_sort competing endogenous rna network identifies mrna biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools
topic Bioinformatics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109009/
https://www.ncbi.nlm.nih.gov/pubmed/34012732
http://dx.doi.org/10.7717/peerj.11412
work_keys_str_mv AT linjinsong competingendogenousrnanetworkidentifiesmrnabiomarkersforoverallsurvivaloflungadenocarcinomatwonovelonlineprecisionmedicinepredictivetools
AT lushubiao competingendogenousrnanetworkidentifiesmrnabiomarkersforoverallsurvivaloflungadenocarcinomatwonovelonlineprecisionmedicinepredictivetools
AT jiangzhijian competingendogenousrnanetworkidentifiesmrnabiomarkersforoverallsurvivaloflungadenocarcinomatwonovelonlineprecisionmedicinepredictivetools
AT huchongjing competingendogenousrnanetworkidentifiesmrnabiomarkersforoverallsurvivaloflungadenocarcinomatwonovelonlineprecisionmedicinepredictivetools
AT zhangzhiqiao competingendogenousrnanetworkidentifiesmrnabiomarkersforoverallsurvivaloflungadenocarcinomatwonovelonlineprecisionmedicinepredictivetools